Dabigatran (Pradax®), a direct thrombin inhibitor oral anticoagulant, was licensed in Canada in November 2010 for stroke prevention in patients with non-valvular atrial fibrillation. It is being promoted as an alternative to warfarin with the purported...
May 2011 This report on Canada's health care performance is a pan-Canadian look at five key commitments of the 2003 First Ministers' Accord on Health Care Renewal and the 2004 10- Year Plan to Strengthen Health...
Listen to Alan Cassels interview Dr Juan Erviti from the Drug Prescribing Service in Navarre, Spain and Dr Jim Wright from the Therapeutics Initiative at UBC regarding the use of bisphophonates for bone fractures. Read Therapeutics Letter 78 ...
Drug and Therapeutics Bulletin The Independent Review of Medical Treatment Vol 49 | No 2 | February 2011 Ever since the concept of the ‘polypill’ was introduced,1,2 it has maintained an almost magical hold over the lay press and many healthcare...